Leadership Team

Yuquan Wei

Chairman, General Manager, Professor of Oncology, Academician of the Chinese Academy of Sciences, former Vice President of Sichuan University, Director of the Clinical Oncology Center and Director of the State Key Laboratory of Biotherapy, West China Hospital, Chairman of the Chinese Medical Biotechnology Association, Head of the National Biotherapy Collaborative Innovation Center, National Comprehensive Head of the technology platform for new drug research and development, chief scientist of the "973" project of the Ministry of Science and Technology, head of the National Natural Science Foundation of China Innovative Research Group, co-editor of Signal Transduction and Targeted Therapy, associate editor of Human Gene Therapy, associate editor of Current Molecular Medicine, Current Cancer Drug Targets. He is responsible for the editorial board of the Asian region, and the editorial board of Scientific Reports and other international magazines. The second batch of specially-appointed professors in the "Major Talents Program" of the Ministry of Education, winner of the National Science Fund for Distinguished Young Scholars in 1997, candidates for the first and second levels of the National "One Hundred Thousand Talents Project", and the 15th "863" Bioengineering in the field of biology and agricultural technology, Leader of the technical subject expert group, member of the 12th Five-Year "863" biotechnology drug subject expert group in the field of biology and medicine, former vice president of the Chinese Medical Association, former executive deputy director of the Department of Biomedicine of the Science and Technology Committee of the Ministry of Education.

Ellen Liu

Vice Chairwoman. Before joined WestVac, Madame Liu was Managing Director, Investment Banking Division of Merrill Lynch Asia, Executive Director of Goldman Sachs China Team, Director for Business Development in China of Pricewaterhouse Coopers. Madame Liu is Vice President of Youth Committee of All-China Federation of Returned Overseas Chinese, Honorary President/Co-founder of Hong Kong Association of Chinese Returned Scholars Limited, President of Sichuan University Hong Kong Alumni Association (2013/17).

Jingjing Cao

Deputy General Manager, Secretary of the Board, Doctor of Law degree in Germany, with more than 10 years of experience in foreign legal affairs, has worked in law firms in Munich and Beijing as senior consultant, lawyer and partner. She was selected by the Ministry of Justice into the national leading talent pool of 1,000 lawyers for foreign-related legal affaires.

Xinru Zhang

Deputy General Manager, Head of Finance, Bachelor of Accounting/Management from Zhongnan University of Economics and Law. Ms. Zhang holds certifications of CICPA, AICPA and CPA Australia. She has about 15 years of experience in corporate financial management. Prior to joining WestVac, she served as Head of Finance of Neurophth, Financial Controller of Hrain Biotechnology and Boyalife Inc. as well as working in audit and assurance at PricewaterhouseCoopers (PwC).

Weidong Li

Deputy General Manager, Head of Business Operation, engaged in pharmaceutical/vaccine market, sales and government access for more than 20 years, used to be Head of Vaccine Market Access in Pfizer China, worked in Pfizer, Sanofi-Pasteur, Xian Janssen and other enterprises, responsible for domestic and foreign drugs/vaccines new products evaluation, launch and bidding&access. Experienced in mature products development and other products life cycle marketing and team management.

Jiyou Shen

Deputy General Manager, Head of Manufacture, Senior Engineer of Pharmaceutical Engineering, engaged in vaccine research and development and production for more than 30 years, used to be Responsible Person of Manufacture of Zhejiang Tianyuan biopharmaceutical Co., Ltd., a subsidiary of GlaxoSmithKline, participate in and took charge of many vaccine research and development and production work, including the vaccines for Acellular DPT, epidemic cerebrospinal meningitis, typhoid fever, flu, epidemic encephalitis B, hemorrhagic fever, 23-valent pneumonia, Hib, hepatitis B.

Huxia Li

Deputy General Manager, Head of Quality, used to be Responsible Person/Authorized Person for Quality of Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Experience in quality research of biological products and vaccines; has more than 20 years of mature management experience in vaccine immunization, blood products production and testing.